相关实验视频
Updated: Jul 13, 2025

07:48
Performing Human Skeletal Muscle Xenografts in Immunodeficient Mice
Published on: September 16, 2019
9.9K
RGX365的神经发生效应改善骨肌肉缩
Hye-Jin Lee1, Hui-Ji Choi2, Sang-Ah Lee3,4
1Department of Chemistry, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Nutrients
|October 14, 2023
概括
RGX365是一种罕见的金氏化物混合物,可以对抗与年龄相关的肌肉缩. 这种化合物增强肌肉细胞的生长和再生,改善老化小鼠的肌肉纤维大小.
科学领域:
- 老年学是指老年学的学科.
- 肌肉生理学 肌肉生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 与年龄相关的骨肌缩,或缩症,降低了生活质量,并使疾病的预后恶化.
- 识别有效的干预措施对萨尔科佩尼亚是健康的衰老至关重要的.
研究的目的:
- 为了评估RGX365的疗效,一个罕见的金氏化物混合物,在改善骨肌肉缩.
- 研究RGX365对肌肉衰老的细胞和动物模型的肌肉效应.
主要方法:
- 评估RGX365对小鼠肌肉细胞 (C2C12) 差异化和甲诱导的缩的影响.
- 通过免疫光学分析了肌管直径和肌重链 (MyHC) 表达.
- 在一个月的时间内,口服RGX365给老年 (23个月大) 麻性小鼠.
主要成果:
- RGX365促进了肌细胞分化,并增加了MyHC的表达.
- RGX365减弱了缩标志物Atrogin-1和MuRF1.1的表达.
- 在老年小鼠中,口服RGX365管理改善了肌肉纤维大小和骨肌肉再生标志物.
结论:
- 罕见的金氏化物,如RGX365中的那些,显示出对骨肌肉缩的治疗剂的潜力.
- RGX365作为类固醇受体的激动剂,改善长期使用的肌肉缩.
相关概念视频
Disorders of the Skeletal Muscle
973
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
973
Formation of Muscle Fibers from Myoblasts
4.9K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
4.9K
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Skeletal Muscle Relaxants: Adverse Effects
377
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
377
Cross-bridge Cycle
117.6K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.6K
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K

